Ianiro, Gianluca
 Distribuzione geografica
Continente #
EU - Europa 6.173
NA - Nord America 5.373
AS - Asia 2.931
SA - Sud America 637
AF - Africa 54
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 10
Totale 15.202
Nazione #
US - Stati Uniti d'America 5.242
DE - Germania 1.897
IT - Italia 1.372
SG - Singapore 1.118
CN - Cina 995
SE - Svezia 955
BR - Brasile 573
FR - Francia 340
IE - Irlanda 321
UA - Ucraina 306
GB - Regno Unito 240
ID - Indonesia 199
FI - Finlandia 158
IN - India 153
RU - Federazione Russa 130
PL - Polonia 129
KR - Corea 103
CA - Canada 89
TR - Turchia 83
HK - Hong Kong 67
NL - Olanda 63
BE - Belgio 37
CZ - Repubblica Ceca 37
JP - Giappone 36
CH - Svizzera 34
ES - Italia 34
AT - Austria 32
MX - Messico 28
IR - Iran 26
AU - Australia 22
VN - Vietnam 22
IQ - Iraq 17
TW - Taiwan 16
AR - Argentina 15
PK - Pakistan 14
CL - Cile 13
CO - Colombia 12
EC - Ecuador 12
GR - Grecia 12
LT - Lituania 12
RO - Romania 12
TN - Tunisia 10
MA - Marocco 9
PT - Portogallo 9
BD - Bangladesh 8
CI - Costa d'Avorio 8
AZ - Azerbaigian 7
EU - Europa 7
IL - Israele 7
JO - Giordania 7
UZ - Uzbekistan 7
ZA - Sudafrica 7
LK - Sri Lanka 6
PH - Filippine 6
BY - Bielorussia 5
EG - Egitto 5
HR - Croazia 5
HU - Ungheria 5
PE - Perù 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BO - Bolivia 4
CY - Cipro 4
DZ - Algeria 4
A2 - ???statistics.table.value.countryCode.A2??? 3
KZ - Kazakistan 3
MY - Malesia 3
NG - Nigeria 3
NO - Norvegia 3
RS - Serbia 3
SA - Arabia Saudita 3
BG - Bulgaria 2
BZ - Belize 2
CR - Costa Rica 2
DK - Danimarca 2
GE - Georgia 2
GG - Guernsey 2
HN - Honduras 2
IS - Islanda 2
KE - Kenya 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
SC - Seychelles 2
UY - Uruguay 2
YE - Yemen 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
CG - Congo 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GT - Guatemala 1
JM - Giamaica 1
KW - Kuwait 1
Totale 15.192
Città #
Chandler 1.053
Singapore 601
Ashburn 433
Dublin 319
Rome 240
San Mateo 195
Jakarta 193
Ann Arbor 184
Jacksonville 181
Milan 158
Cattolica 148
Wilmington 139
Boston 134
New York 129
Nanjing 127
Nürnberg 121
Hefei 102
Beijing 101
Woodbridge 100
Fairfield 98
Marseille 97
Seoul 95
Princeton 87
Warsaw 87
Moscow 85
Los Angeles 83
Redwood City 81
Houston 79
Chicago 72
Boardman 66
Lawrence 64
Dearborn 62
Izmir 62
Seattle 58
Munich 56
Frankfurt am Main 53
Helsinki 52
Hong Kong 52
São Paulo 49
The Dalles 47
Nuremberg 43
Hangzhou 40
Las Vegas 39
Nanchang 39
London 38
Brussels 35
Cambridge 35
Pune 35
Shanghai 35
Düsseldorf 34
Hyderabad 33
Leawood 33
North Bergen 32
Shenyang 27
Augusta 26
Bremen 25
Redmond 24
Hebei 23
Norwalk 23
Toronto 23
Zhengzhou 23
Belo Horizonte 22
Ottawa 22
Tianjin 22
Trieste 22
Changsha 21
Turku 21
Washington 21
Mountain View 20
San Francisco 20
Jiaxing 18
Padova 18
Kraków 17
University Park 17
Verona 17
Andover 16
Fremont 16
Kunming 16
Mexico City 16
Vienna 16
Guangzhou 15
Lancaster 15
Lappeenranta 15
Porto Alegre 15
Falls Church 14
Bologna 13
Falkenstein 13
Council Bluffs 12
Kish 12
Naples 12
Phoenix 12
Bari 11
Brno 11
Genoa 11
Melbourne 11
Paris 11
Santa Clara 11
Zurich 11
Arezzo 10
Baghdad 10
Totale 7.411
Nome #
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns 383
From small nodule to overt HCC: a multistep process of carcinogenesis as seen during surveillance 293
gc) Water-immersion technique during standard upper endoscopy may be useful to drive the biopsy sampling of duodenal mucosa in children with celiac disease. 266
Gut microbiota in anxiety and depression: Pathogenesis and therapeutics 218
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 212
Wheat desensitization treatment in patients with gluten sensitivity 210
The role of intestinal microbiota and the immune system 205
gc) Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. 192
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy 184
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 177
White mulberry supplementation as adjuvant treatment of obesity 168
The role of diet on gut microbiota composition 168
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 168
The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial 167
Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota 163
Gut microbiota in autism and mood disorders 149
Nutritional aspects of Helicobacter pylori infection 148
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 143
Can chronic gastritis cause increase of fecal calprotectin concentrations? 141
Can chronic gastritis cause an increase in fecal calprotectin concentrations? 141
Fecal microbiota transplantation: Past, present and future perspectives 140
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 137
Assessment of neurological manifestations in hospitalized patients with COVID-19 137
13C-octanoic acid breath test to study gastric emptying time 135
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns. 131
Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns 131
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 125
Gut microbiota in autism and mood disorders 122
Role of gut microbiota in food tolerance and allergies 120
Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy 119
Moderately Severe Acute Pancreatitis Associated With Riluzole 115
Microscopic colitis 112
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders 110
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 107
Confirmed or unconfirmed cases of 2019 novel coronavirus pneumonia in Italian patients: a retrospective analysis of clinical features 107
Coeliac disease: an old or a new disease? History of a pathology 106
Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection 106
Gut microbiota and metabolic syndrome 105
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 105
Gut microbiome, big data and machine learning to promote precision medicine for cancer 105
Therapeutic modulation of gut microbiota: current clinical applications and future perspectives. 104
Levothyroxine absorption in health and disease, and new therapeutic perspectives 102
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome 101
European consensus conference on faecal microbiota transplantation in clinical practice 101
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 100
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 99
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 99
Current technologies for the endoscopic assessment of duodenal villous pattern in celiac disease 98
Role of N-acetyl-cisteine in the treatment of H. pylori 95
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases 95
Autism, gastrointestinal symptoms and modulation of gut microbiota by nutritional interventions 95
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 93
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: a pre-post analysis in a Third Level Referral Center 93
Detection of rare G3P[19] group A rotavirus in human patient, Italy 92
Key determinants of success in fecal microbiota transplantation: From microbiome to clinic 91
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center 91
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 89
Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections 86
Effects of proton pump inhibitors on the gastric mucosa-associated microbiota in dyspeptic patients 85
Pancreatic function assessment 83
Gastrointestinal involvement of autism spectrum disorder: focus on gut microbiota 82
The role of biomarkers in diverticular disease 81
Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review 79
Gut microbiota and inflammatory bowel disease: an update 79
A Durum Wheat Variety-Based Product Is Effective in Reducing Symptoms in Patients with Non-Celiac Gluten Sensitivity: A Double-Blind Randomized Cross-Over Trial 78
The facts about food after cancer diagnosis: A systematic review of prospective cohort studies 78
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 77
Diet-Induced Alterations in Gut Microbiota Composition and Function 77
The human gut microbiota and virome: Potential therapeutic implications 76
Barrett's oesophagus and associated dysplasia are not equally distributed within the esophageal circumference 76
How to define a quadruple aim framework to assess value in critical pathway of the patients with Clostridioides difficile infection 73
Culture-guided treatment approach for Helicobacter pylori infection: review of the literature 72
Ipilimumab Adjuvant Therapy in Melanoma 72
Helicobacter pylori in metabolic related diseases 72
Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics 71
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic 71
Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients 70
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 69
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 68
Digestive Enzyme Supplementation in Gastrointestinal Diseases 68
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials 68
Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome 68
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 68
The role of diet in shaping human gut microbiota 65
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer 65
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases 64
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 63
FECAL CALPROTECTIN AND NEED OF MULTIPLE MICROBIOTA TRANSPLANTATION INFUSIONS IN CLOSTRIDIUM DIFFICILE INFECTION 63
Clinical research coordinators: Key components of an efficient clinical trial unit 62
Modulation of gut microbiota in patients with IBS and systemic nickel allergy after diet and probiotic supplementation: a pilot study 62
Proteomics and metabolomics approaches towards a functional insight onto autism spectrum disorders: Phenotype stratification and biomarker discovery 62
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms 61
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center 61
Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement 60
Gut Virome and Inflammatory Bowel Disease 60
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study 60
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 60
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 58
From Regular Catharsis with Castor Oil to Recognizing the Importance of the Intestinal Microbiota 58
Nonlinear machine learning pattern recognition and bacteria-metabolite multilayer network analysis of perturbed gastric microbiome 58
Totale 10.898
Categoria #
all - tutte 75.089
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.089


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202098 0 0 0 0 0 0 0 0 0 0 0 98
2020/20211.151 62 121 29 97 140 97 124 26 120 81 199 55
2021/20221.370 77 77 38 77 93 66 41 220 55 82 275 269
2022/20233.109 407 387 227 442 186 375 155 274 377 83 112 84
2023/20242.032 101 482 94 115 87 274 173 95 55 111 213 232
2024/20254.042 118 153 350 132 324 151 167 242 565 628 1.098 114
Totale 15.572